Results for the substance covid 19 vaccine chadox1 s recombinant

The COVID-19 vaccine (ChAdOx1-S [recombinant]) is used to prevent infection with the SARS-CoV-2 virus, responsible for the COVID-19 pandemic. This vaccine uses a non-replicating viral vector based on a genetically modified chimpanzee adenovirus (ChAdOx1) to express the SARS-CoV-2 spike protein.

The vaccine is administered intramuscularly, usually in two doses, 4-12 weeks apart, according to the manufacturer's recommendations. It is intended for adults and adolescents, and its efficacy has been demonstrated in preventing severe forms of COVID-19, hospitalizations, and deaths.

Common side effects include pain at the injection site, fever, fatigue, headache, and muscle aches. In very rare cases, thrombotic events associated with thrombocytopenia have been reported.

The COVID-19 vaccine (ChAdOx1-S [recombinant]) is an essential measure in combating the pandemic, helping to reduce virus transmission and protect public health.